Find out how Evista (raloxifene) helps treat osteoporosis and reduce breast cancer risk, and why DEXA scans in San Francisco at KALOS are essential to track progress.
If you’ve been diagnosed with osteoporosis or are at risk for bone loss after menopause, your doctor may recommend Evista. It’s a well-established treatment option that offers a unique benefit: it not only helps strengthen bones but also lowers the risk of breast cancer in some women.
Here’s everything you need to know about Evista medication, including how it works, who it’s for, and how to track its effectiveness.
Evista is the brand name for raloxifene, a prescription medication approved to:
What is Evista used for?
Evista is primarily used to preserve bone density and lower fracture risk in the spine—not hips. It also offers estrogen-like benefits to bone without increasing the risk of uterine or breast cancer.
Evista belongs to a class of drugs called Selective Estrogen Receptor Modulators (SERMs). It has a dual effect:
This makes it a unique option for women seeking both bone protection and cancer risk reduction—without hormone replacement therapy.
Evista may be a good fit if you:
It may not be ideal if you:
Always consult your doctor about your personal risk profile before starting Evista.
To measure the effectiveness of Evista medication, regular DEXA scans are essential. These scans show:
At KALOS, our DEXA Scan San Francisco service provides accurate, data-driven insights to guide your osteoporosis treatment plan.
If you’re taking Evista or considering it, make sure you track your progress with a DEXA scan. At KALOS, we’ll help you measure your bone health and make informed decisions based on real data.
Schedule your scan today at KALOS—your journey to data-driven bone protection starts now.
Bay Area residents trust KALOS to deliver results. We proudly serve the entire Bay Area including the following locations: